Duration of remission after halving of the etanercept dose in patients with ankylosing spondylitis: a randomized, prospective, long-term, follow-up study

Fabrizio Cantini, Laura Niccoli, Emanuele Cassarà, Olga Kaloudi, Carlotta NanniniDivision of Rheumatology, Misericordia e Dolce Hospital, Prato, ItalyBackground: The aim of this study was to evaluate the proportion of patients with ankylosing spondylitis maintaining clinical remission...

Full description

Bibliographic Details
Main Authors: Nannini C, Kaloudi O, Cassara E, Niccoli L, Cantini F
Format: Article
Language:English
Published: Dove Medical Press 2013-01-01
Series:Biologics: Targets & Therapy
Online Access:http://www.dovepress.com/duration-of-remission-after-halving-of-the-etanercept-dose-in-patients-a11872